Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Accord-UK Ltd (Trading style: Accord), Whiddon Valley, Barnstaple, Devon, EX32 8NS
Zolmitriptan 2.5 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Zolmitriptan 2.5 mg film-coated tablets are light yellow, round, biconvex tablets with ‘ZL 2.5’ debossed on one side. |
Each 2.5 mg film-coated tablet contains 2.5 mg zolmitriptan
Excipient with know effect: Each 2.5 mg film-coated tablet contains 87.7 mg lactose anhydrous.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Zolmitriptan |
Zolmitriptan has been demonstrated to be a selective agonist for the vascular human recombinant 5HT1B and 5HT1D receptor subtypes. Zolmitriptan is a high affinity 5HT1B/1D receptor agonist with modest affinity for 5HT1A receptors. |
| List of Excipients |
|---|
|
Tablet core: Lactose, anhydrous Tablet coating: Hypromellose (E464) |
Aluminium/aluminium blisters.
Pack sizes: 3, 6, 12 or 18 tablets.
Not all pack sizes may be marketed.
Accord-UK Ltd (Trading style: Accord), Whiddon Valley, Barnstaple, Devon, EX32 8NS
PL 0142/1196
28/07/2009 / 03/07/2013
| Drug | Countries | |
|---|---|---|
| ZOLMITRIPTAN | Austria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
